Compositions comprising constituents, derivatives or extracts of cannabis
US-2024415913-A1 · Dec 19, 2024 · US
Cannabidiol-type cannabinoid compound
US2022016048A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2022016048-A1 |
| Application number | US-201917296066-A |
| Country | US |
| Kind code | A1 |
| Filing date | Nov 20, 2019 |
| Priority date | Nov 21, 2018 |
| Publication date | Jan 20, 2022 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a cannabidiol (CBD) type cannabinoid compound for use as a medicament. The CBD-type cannabinoid, cannabidiol-C4 (CBD-C4), is a naturally occurring cannabinoid that can be found in minor quantities in the cannabis plant. Furthermore, the cannabinoid can be produced by synthetic means. Disclosed herein are data which demonstrate the efficacy of CBD-C4 in models of disease. In addition, a method for the production of CBD-C4 is described.
First claim
Opening claim text (preview).
1 . Cannabidiol-C4 (CBD-C4) for use as a medicament. 2 . CBD-C4 for use according to claim 1 , wherein the CBD-C4 is in the form of a plant extract. 3 . CBD-C4 for use according to claim 2 , wherein the CBD-C4 is in the form of a highly purified plant extract. 4 . CBD-C4 for use according to claim 3 , wherein the CBD-C4 is comprises at least 80% (w/w) CBD-C4. 5 . CBD-C4 for use according to claim 3 , wherein the CBD-C4 is comprises at least 95% (w/w) CBD-C4. 6 . CBD-C4 for use according to claim 1 , wherein the CBD-C4 is in the form of a synthetic compound. 7 . CBD-C4 for use according to any of the preceding claims, wherein the dose of CBD-C4 is greater than 100 mg/kg/day. 8 . CBD-C4 for use according to any of the preceding claims, wherein the dose of CBD-C4 is less than 100 mg/kg/day. 9 . A composition for use as a medicament comprising cannabidiol-C4 (CBD-C4) and one or more pharmaceutically acceptable excipients. 10 . Cannabidiol-C4 (CBD-C4) for use in the treatment of epilepsy. 11 . Cannabidiol-C4 (CBD-C4) for use in the treatment of schizophrenia. 12 . A process for the preparation of cannabidiol-C4 (CBD-C4).
Assignees
Inventors
Classifications
Cannabis · CPC title
- A61K31/658Primary
o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol · CPC title
Antiepileptics; Anticonvulsants · CPC title
Purification; separation; Use of additives, e.g. for stabilisation {(C07C37/004 and C07C37/005 take precedence)} · CPC title
Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2022016048A1 cover?
- The present invention relates to a cannabidiol (CBD) type cannabinoid compound for use as a medicament. The CBD-type cannabinoid, cannabidiol-C4 (CBD-C4), is a naturally occurring cannabinoid that can be found in minor quantities in the cannabis plant. Furthermore, the cannabinoid can be produced by synthetic means. Disclosed herein are data which demonstrate the efficacy of CBD-C4 in models of…
- Who is the assignee on this patent?
- Gw Res Ltd
- What technology area does this patent fall under?
- Primary CPC classification A61K31/658. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Jan 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).